Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The Duration of Untreated Illness (DUI), defined as the time elapsing between the onset of a disorder and the beginning of the first pharmacological treatment, has been increasingly investigated as a predictor of outcome and course across different psychiatric disorders. Purpose of this naturalistic study was to evaluate the influence of DUI on treatment response and remission in a sample of patients with obsessive-compulsive disorder (OCD). METHODS: Sixty-six outpatients with a DSM-IV diagnosis of OCD were included in the study. Patients received, according to their clinical conditions, an open pharmacological treatment of 12 weeks and were evaluated by the administration of the Yale Brown Obsessive Compulsive Scale (Y-BOCS) at baseline and endpoint. Treatment response was defined as a decrease .25% on Y-BOCS score compared to baseline, while remission was defined as an endpoint Y-BOCS total score #10. A logistic regression was performed considering DUI as the independent continuous variable and treatment response and remission as the dependent variables. Moreover, the sample was divided into two groups according to a categorical cut-off for the DUI of 24 months and odds ratios (OR) were calculated on the basis of the same variables. RESULTS: DUI, considered as a continuous variable, was not predictive of treatment response (OR51.00, P50.15) nor remission (OR51.00, P50.59). When considered as a categorical variable, however, a DUI # 24 months was predictive of treatment response (OR50.27, P50.03). CONCLUSIONS: Results from the present naturalistic study suggest a complicated relationship between DUI and treatment outcome in OCD encouraging further investigation with larger samples in order to better define long versus short DUI in this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771 · cited 1×
“Obsessive–compulsive disorder (OCD) is an anxiety disorder with a lifetime prevalence of approximately 2% in general population (Ruscio et al. 2008) and is considered a chronic, highly impairing condition, often comorbid with other mental disorders (Goodman and Lydiard 2007; Koran 2000).”
BackgroundMataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635 · cited 2×
“Nonetheless, up to 40–60% of patients do not completely recover after a single SRI trial and are eligible for second-line treatments with a combination of SRIs and other compounds such as antipsychotics (both typical and atypical) (Bloch et al. 2006; Marazziti et al. 2008), proserotonergic compounds (e.”
BackgroundSareen, J., Jagdeo, A., Cox, B. J., Clara, I., ten Have, M., Belik, S.-L., de Graaf, R., & Stein, M. B. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.3.357 · Cited by 470
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Self-citationReliability of the structured clinical interview for DSM-iII-R: an evaluative review
Segal, D. L., Hersen, M., & Van Hasselt, V. B. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90025-6 · Cited by 293 · cited 1×
“Diagnoses were made by trained psychiatrists through the administration of SCID-I (First et al. 1997) and SCID-II (Segal et al. 1994).”
MethodMeta-analysis of brain volume changes in obsessive-compulsive disorder
Rotge, J.-Y., Guehl, D., Dilharreguy, B., Tignol, J., Bioulac, B., Allard, M., Burbaud, P., & Aouizerate, B. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.019 · Cited by 284 · cited 1×
“In other words, an early adequate treatment may act on a less pathological substrate and/or prevent the development of structural changes that accompany the progression of the disease (Rotge et al. 2009).”
BackgroundClinical predictors of response to cognitive-behavioral therapy for obsessive–compulsive disorder
Keeley, M. L., Storch, E. A., Merlo, L. J., & Geffken, G. R. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.04.003 · Cited by 261 · cited 1×
“Furthermore, severity of illness and comorbidity with obsessive–compulsive personality disorder (OCPD) have been indicated as important predictors of response to cognitive-behavioral therapy in patients with OCD (Keeley et al. 2008).”
BackgroundClinical Predictors of Drug Response in Obsessive-Compulsive Disorder
Erzegovesi, S., Cavallini, M. C., Cavedini, P., Diaferia, G., Locatelli, M., & Bellodi, L. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00006 · Cited by 224 · cited 2×
“2006), early age at onset, “poor insight” subtype, somatic obsessions (Erzegovesi et al. 2001) and hoarding subtype (Hollander et al.”
BackgroundHollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197 · cited 2×
“Treatment response was defined as a decrease 25% on total Y-BOCS scores compared to baseline (Hollander et al. 2003), while remission was defined as an endpoint Y-BOCS total score 10 (Stein et al. 2007).”
MethodSelf-citation
Cited by
Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse [CME]
Eisen, J. L., Sibrava, N. J., Boisseau, C. L., Mancebo, M. C., Stout, R. L., Pinto, A., & Rasmussen, S. A. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07657 · Cited by 248
Early intervention for obsessive compulsive disorder: An expert consensus statement
Fineberg, N. A., Dell'Osso, B., Albert, U., Maina, G., Geller, D., Carmi, L., Sireau, N., Walitza, S., Grassi, G., Pallanti, S., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.002 · Cited by 158
Self-citationFineberg, N. A., Hollander, E., Pallanti, S., Walitza, S., Grünblatt, E., Dell’Osso, B. M., Albert, U., Geller, D. A., Brakoulias, V., Janardhan Reddy, Y. C., et al. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000314 · Cited by 161
Self-citationGarcía-Soriano, G., Rufer, M., Delsignore, A., & Weidt, S. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.07.009 · Cited by 151
“, 2010), and OCD symptoms untreated for more than 2 years are associated with worse treatment response (Dell'Osso et al., 2010).”
BackgroundFineberg, N. A., Reghunandanan, S., Simpson, H. B., Phillips, K. A., Richter, M. A., Matthews, K., Stein, D. J., Sareen, J., Brown, A., & Sookman, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.003 · Cited by 150
Metadata
- Authors
- Dell’Osso, B., Buoli, M., Hollander, E., & Altamura, A. C.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2009-12-14
- Volume
- 11
- Issue
- 1
- Pages
- 59-65
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2132908303
- Cited by
- 96
- References
- 14
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder. https://app.cochat.ai/papers/10.3109/15622970903418544
- The paper
- Dell’Osso, B., Buoli, M., Hollander, E., & Altamura, A. C. (2010). Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622970903418544
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.